Related Experiment Video
Updated: Jan 31, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care
Rhona Eveleigh1, Esther Muskens2, Peter Lucassen3
1Nursing Home Physician, Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Background:
Antidepressant use has increased exponentially in recent decades, mostly due to long continuation.
Aim:
To assess the effectiveness of a tailored recommendation to withdraw antidepressant treatment.
Design & Setting:
Randomised controlled trial in primary care (PANDA study) in the Netherlands.
Method:
Long-term antidepressant users (≥9 months) were selected from GPs prescription databases. Patients were diagnosed with the Composite International Diagnostic Interview (CIDI). Long-term users without indication for maintenance treatment (overtreatment) were selected. The intervention consisted of disclosure of the current psychiatric diagnosis combined with a tailored treatment recommendation. Patients were followed for 12 months.
Results:
The study included 146 participants from 45 family practices. Of the 70 patients in the intervention group, 34 (49%) did not comply with the advice to stop their antidepressant medication. Of the 36 (51%) patients who agreed to try, only 4 (6%) succeeded. These figures were consistent with the control group, where 6 (8%) of the 76 patients discontinued antidepressant use successfully. Patients who were recommended to discontinue their antidepressant medication reported a higher relapse rate than the control group (26% versus 13%, P = 0.05).
Conclusion:
Changing inappropriate long-term antidepressant use is difficult.
Related Concept Videos
Antidepressant Drugs: Overview
Clinical Trials: Overview
Trial and Error and Algorithm
Antidepressant Drugs: MAOIs and Other Agents
Clinical Trials
There are four phases in a clinical trial. A phase one...
Inhaled Medications

